In non-small cell lung cancer (NSCLC), Wiggins JF et al.11 chemically synthesized miR-34a and a lipid-based transport vehicle, and found that this combination effectively blocked cell proliferation by targeting cyclin-dependent kinase 4 (CDK4) in vitro and in vivo. The gene discussed is CDK4; the disease is non-small cell lung carcinoma.